PCM1-JAK2 in Therapy Related Neoplasms
Condition(s):Detection of PCM1-JAK2 Fusion Gene by FISH in the Two Types of t-MDS/AML and Relationship Between PCM1-JAK2 Fusion Gene and Cumulative Dose, Dose IntensityLast Updated:May 9, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Detection of PCM1-JAK2 Fusion Gene by FISH in the Two Types of t-MDS/AML and Relationship Between PCM1-JAK2 Fusion Gene and Cumulative Dose, Dose IntensityLast Updated:May 9, 2019Unknown status
Condition(s):Secondary Myelodysplastic Syndrome; Therapy-Related Myelodysplastic SyndromeLast Updated:January 10, 2024Recruiting
Condition(s):Therapy Related Myelodysplastic Syndrome and Therapy Related Acute Myeloid LeukemiaLast Updated:May 19, 2020Completed
Condition(s):Myelodysplastic Syndrome; Acute Myeloid LeukemiaLast Updated:February 11, 2014Completed
Condition(s):Parkinson Disease; Upper Extremity Dysfunction; Therapy-Related MDSLast Updated:September 18, 2023Completed
Condition(s):Recurrent Chronic Myelomonocytic Leukemia; Recurrent Myelodysplastic Syndrome; Refractory Chronic Myelomonocytic Leukemia; Refractory Myelodysplastic Syndrome; Therapy-Related Myelodysplastic SyndromeLast Updated:December 22, 2023Recruiting
Condition(s):Chronic Myelomonocytic Leukemia; Myelodysplastic Syndrome; Recurrent Myelodysplastic Syndrome; Refractory Myelodysplastic Syndrome; Therapy-Related Myelodysplastic SyndromeLast Updated:October 27, 2023Recruiting
Condition(s):Myelodysplastic Syndrome; Previously Treated Myelodysplastic Syndrome; Refractory High Risk Myelodysplastic Syndrome; Secondary Myelodysplastic Syndrome; Therapy-Related Myelodysplastic SyndromeLast Updated:October 19, 2021Completed
Condition(s):Chronic Lymphocytic LeukemiaLast Updated:May 8, 2018Completed
Condition(s):Myelodysplastic Syndromes, de Novo; Myelodysplastic Syndromes, Secondary; Myelodysplastic Syndromes, Previously Treated; Treatment-Related Acute Myeloid Leukemia; Therapy-Related Myelodysplastic Syndrome; Acute Lymphoblastic Leukemia, in Relapse; Acute Lymphoblastic Leukemia With Failed Remission; Lymphoblastic Lymphoma, in Relapse; Lymphoblastic Lymphoma, Refractory; Acute Leukemia of Ambiguous Lineage in Relapse; Acute Leukemia of Ambiguous LineageLast Updated:December 5, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.